Anti-CMV antibody [ZR456] (STJ180674)

SPECIFICATIONS
ClonalityMonoclonal
HostRabbit
ConjugationUnconjugated
IsotypeIgG2k/IgG1k
ImmunogenPurified human CMV antigen
STJ180674
🚚 Free UK Delivery on orders over £150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionRabbit monoclonal CMV antibody for use in IHC-P in human samples. Datasheet included with dilution recommendations, and related reagents.
ApplicationsIHC-P
HostRabbit
ReactivityHuman
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

ClonalityMonoclonal
Clone IDZR456
IsotypeIgG2k/IgG1k
ConjugationUnconjugated
PurificationAffinity purified
Dilution Range1:100-200
FormulationTris-HCI buffer containing stabilizing protein (BSA) and <0.1% ProClin
Storage InstructionStore at 2‐8°C for up to 24 months. Predilute: Ready to use, no reconstitution necessary. Concentrate: Use dilution range and appropriate lab‐standardized diluent. Stability after dilution: 7 days at 24°C, 3 months at 2‐8°C, 6months at ‐20°C.

Target Information

ImmunogenPurified human CMV antigen
SpecificityPositive Control: CMV infected tissue

Additional Info

Background Zeta s CMV Antibody. Zeta s recombinant rabbit antibody recognizes Cytomegalovirus (CMV) , an opportunistic pathogen infecting the lungs, kidneys, gut, and other organs in situations where an individual is immunologically immature, such as the fetus and neonate. CMV infection also occurs in immunosuppressed patients, such as transplant patients, patients undergoing chemotherapy, and those with HIV infection. Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop CMV infections. Immunohistochemistry with the CMV antibody can be used to detect CMV infection in formalin-fixed and paraffin-embedded tissues. CMV p65 antigen was also detected in the leukocytes of the peripheral blood and BALF during the early phase of CMV disease. Zeta Corporation is a leader in recombinant monoclonal IVD antibodies for immunohistochemistry (IHC) offering 400+ tumor and tissue specific relevant products developed by a pathologist for pathologists. Visit Precision Recombinant Antibodies – IVD Antibodies – About Zeta Corporation (zeta-corp.com) to learn more about Zeta Corporation.

Information sourced from Uniprot.org

Citations

Product Review

Well-cited Academic Publications
KO-Validated 700+ Lines
Technical Support Expert Scientific Team
1-Year Guarantee Antibodies & Proteins